20.84

2.34% -0.50

After Hours: 20.66 -0.18 -0.86%

Hims Hers Health Inc (HIMS)

Overview News Price History Option Chain Financials Why HIMS Down? Discussions Forecast

Hims Hers Health Inc stock is traded at $20.84, with a volume of 21.60M. It is down -2.34% in the last 24 hours and up +31.73% over the past month. Hims & Hers Health Inc operates telehealth platforms, providing access to treatments for various chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. The company connects patients to licensed healthcare professionals who can prescribe medications, with prescriptions fulfilled online through licensed pharmacies. In addition, it offers access to various non-prescription health and wellness products. Through the Hims & Hers mobile applications, the company also offers access to educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Geographically, it derives maximum revenue from the USA.

Previous Close:

$21.34

Open:

$21.7

24h Volume:

21.60M

Relative Volume:

0.69

Market Cap:

$4.75B

Revenue:

$2.35B

Net Income/Loss:

$128.37M

P/E Ratio:

39.92

EPS:

0.5221

Net Cash Flow:

$57.42M

1W Performance:

-9.98%

1M Performance:

+31.73%

6M Performance:

-62.02%

1Y Performance:

-43.74%

1-Day Range:

$20.57

$22.00

1-Week Range:

$20.57

$24.39

52-Week Range:

$13.74

$70.43

Hims Hers Health Inc Stock (HIMS) Company Profile

Name

Hims Hers Health Inc

Sector

Healthcare (1114)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

415-851-0195

Address

2269 CHESTNUT ST, SAN FRANCISCO

Employee

2,442

Twitter

Next Earnings Date

2025-02-24

Latest SEC Filings

HIMS's Discussions on Twitter

Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HIMS Hims Hers Health Inc	20.84	4.86B	2.35B	128.37M	57.42M	0.5221
TAK Takeda Pharmaceutical Co Adr	18.29	56.99B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	116.71	48.94B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.74	43.30B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	29.46	33.94B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	541.60	23.31B	3.18B	1.33B	1.04B	27.90

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-10-26	Upgrade	BofA Securities	Underperform → Neutral
Mar-10-26	Upgrade	Citigroup	Sell → Neutral
Mar-09-26	Upgrade	Needham	Hold → Buy
Feb-24-26	Downgrade	BTIG Research	Buy → Neutral
Jan-12-26	Initiated	Evercore ISI	In-line
Dec-09-25	Initiated	Barclays	Overweight
Oct-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy
Apr-29-25	Downgrade	TD Cowen	Buy → Hold
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-25	Downgrade	Citigroup	Neutral → Sell
Jan-07-25	Initiated	BTIG Research	Buy
Dec-17-24	Initiated	Morgan Stanley	Overweight
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral
Apr-16-24	Downgrade	Jefferies	Buy → Hold
Apr-10-24	Initiated	Canaccord Genuity	Buy
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform
Feb-26-24	Initiated	Leerink Partners	Market Perform
Dec-07-23	Initiated	Imperial Capital	In-line
Jul-28-23	Initiated	TD Cowen	Outperform
Apr-11-23	Initiated	Robert W. Baird	Neutral
Feb-09-23	Upgrade	Jefferies	Hold → Buy
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral
Sep-07-22	Initiated	Truist	Hold
Jul-15-22	Initiated	SVB Leerink	Underperform
Apr-14-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-10-22	Initiated	Deutsche Bank	Hold
Dec-02-21	Initiated	Jefferies	Hold
Nov-11-21	Upgrade	Piper Sandler	Neutral → Overweight
Jul-06-21	Initiated	BofA Securities	Neutral
May-20-21	Upgrade	Credit Suisse	Neutral → Outperform
Apr-21-21	Initiated	Truist	Hold
Mar-09-21	Initiated	Credit Suisse	Neutral
Mar-02-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Initiated	Citigroup	Neutral
Feb-12-21	Initiated	Piper Sandler	Neutral
Feb-08-21	Initiated	Tigress Financial	Buy

View All

Hims Hers Health Inc Stock (HIMS) Latest News

Mar 25, 2026

Hims & Hers Health Options Spot-On: On March 25th, 136.26K Contracts Were Traded, With 1.06 Million Open Interest - Moomoo

Mar 25, 2026

Hims & Hers: Distressed Valuations Will Not Last For Long (NYSE:HIMS) - Seeking Alpha

Mar 25, 2026

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire

Mar 25, 2026

HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now? - TradingView

Mar 25, 2026

Why is Hims & Hers Health stock down today? - Traders Union

Mar 25, 2026

With Legal Overhang Behind, Hims Looks To Drive Growth via Novo Partnership and International Push - Morningstar

Mar 25, 2026

Hims & Hers Health stock slips 3.33% as resistance holds and sellers dominate near $20.00 support - Traders Union

Mar 25, 2026

Oluyemi Okupe Sells 9,217 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat

Mar 25, 2026

Mar 24, 2026

Hims & Hers Faces Multifaceted Challenges as Investor Confidence Wavers - AD HOC NEWS

Mar 24, 2026

Okupe, Hims & Hers health CFO, sells $219k in shares - Investing.com

Mar 24, 2026

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity - Stock Titan

Mar 24, 2026